PARP ‐1 Inhibition Increases Oxidative Stress in Ets‐1‐Expressing MDA ‐ MB ‐231 Breast Cancer Cells
Cancer Reports · 2025
DOI: 10.1002/cnr2.70119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Magalie Hervieu und 8 weiteren Autor:innen. Beteiligte Einrichtung: CNRS EMR9002 Integrative Structural Biology, Lille, France. Hauptthemen laut MEDLINE: Oxidative Stress, Breast Neoplasms, Poly (ADP-Ribose) Polymerase-1, Poly(ADP-ribose) Polymerase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre National de la Recherche Scientifique, La Ligue contre le Cancer, Comité du Pas-de-Calais.
Abstract (Originalsprache)
Background
The Ets‐1 transcription factor plays a primordial role in regulating the expression of numerous genes implicated in cancer progression. In a previous study, we revealed that poly(ADP‐ribose) polymerase‐1 (PARP‐1) inhibition by PJ‐34 results in Ets‐1 level increase in cells, which is related with cell death of Ets‐1‐expressing cancer cells.
Aims
The mechanism of the antitumor effect of PARP‐1 inhibition was investigated in the Ets‐1‐expressing MDA‐MB‐231 breast cancer cells. Methods and Results We tested the effects of four PARP inhibitors (PARPi) (PJ‐34, Veliparib, Olaparib, and Rucaparib). We first demonstrated that PARPi reduced cells growth through G2/M cell cycle arrest. Next, we evaluated PARP‐1 inhibition effect on oxidative DNA damage in Ets‐1‐overexpressing and Ets‐1‐non‐expressing breast cancer cells and we showed that PARPi led only Ets‐1‐overexpressing cells to accumulate it, which triggers the DNA damage response as revealed by the increase in the level of a panel of DNA damage‐related proteins. Importantly, we demonstrated that PARPi increased reactive oxygen species (ROS), only in Ets‐1‐overexpressing cells and this is accompanied by upregulation of p47 phox expression, a subunit of the NAPDH oxidase (NOX).
Conclusion
These preliminary findings correlate PARPi‐induced oxidative DNA damage/oxidative stress to Ets‐1 expression in breast cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CNRS EMR9002 Integrative Structural Biology, Lille, France.
- Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167-RID-AGE-Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
- Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France.
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US41-UMS2014-PLBS, F-59000, Lille, France; Univ. Lille, CNRS, UMR8576-UGSF-Structural and Functional Glycobiology Unit, Lille, France.
- Département de Biologie, Faculté des Sciences, Université Chouaïb Doukkali, El Jadida, Morocco.
ORCID-Profile: Emilie Floquet, Souhaila Choul-Li
Förderung
- Centre National de la Recherche Scientifique
- La Ligue contre le Cancer, Comité du Pas-de-Calais
Zitieren
APA
Hervieu, M., Legrand, A. J., Floquet, E., Idziorek, T., Spriet, C., Monté, D., Villeret, V., Aumercier, M., & Choul-Li, S. (2025). PARP ‐1 Inhibition Increases Oxidative Stress in Ets‐1‐Expressing MDA ‐ MB ‐231 Breast Cancer Cells. Cancer Reports. https://doi.org/10.1002/cnr2.70119
Vancouver
Hervieu M, Legrand AJ, Floquet E, Idziorek T, Spriet C, Monté D, et al. PARP ‐1 Inhibition Increases Oxidative Stress in Ets‐1‐Expressing MDA ‐ MB ‐231 Breast Cancer Cells. Cancer Reports. 2025. doi:10.1002/cnr2.70119
BibTeX
@article{Hervieu2025,
author = {Hervieu, Magalie and Legrand, Arnaud J and Floquet, Emilie and Idziorek, Thierry and Spriet, Corentin and Monté, Didier and Villeret, Vincent and Aumercier, Marc and Choul-Li, Souhaila},
title = {PARP ‐1 Inhibition Increases Oxidative Stress in Ets‐1‐Expressing MDA ‐ MB ‐231 Breast Cancer Cells},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70119}
}
EUVIMED